Skip to content
★ Sign in to follow
ES

Ethan Shen PhD

CEO
YD Bio Ltd
Insider activity · 24 months3 buys0 salesCumulative net flow
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€111k
▼ Sales (0 ops.)
—

Latest filing published 16 Sept 2026 for YD Bio Ltd, €42k.

Filing timeline

BuySale
Ethan Shen PhD

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 16 Sept 2026 · 53 days ago · €42k
    +30.9%
    Entry US$3.24 · Close 22 Oct 2026 US$4.24
  • Filed 10 Sept 2026 · 59 days ago · €10k
    +58.2%
    Entry US$0.39 · Close at T+30 US$0.62
  • Filed 08 Sept 2026 · 61 days ago · €58k
    +71.5%
    Entry US$0.39 · Close at T+30 US$0.67

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Ethan Shen PhD: trading record in brief

Ethan Shen PhD appears in our data through filings on YD Bio Ltd shares, published by SEC (Form 4). Over a trading history stretching from 4 September 2026 to 14 September 2026, the count stands at 3 filings.

On the market, this insider has only ever bought: 3 purchases, €111k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

Half of the purchases are above €42k and half below. As a share of market capitalisation, the median purchase stands at 0.011%, based on 3 purchases. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

The record was last updated on 16 September 2026 with an open-market purchase (€42k) in YD Bio Ltd. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Ethan Shen PhD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    CEOExecutivesYD Bio Ltd
    48,895 USD32SEC
    12,700 shares@ US$3.850.011% mcap38.1% of flowOrdinary SharesSEC:0001213900-26-100506:0
    Canonical exit: 13 Dec 2026 (T+90)
  • ▲
    CEOExecutivesYD Bio Ltd
    12,183 USD26SEC
    3,100 shares@ US$3.930.0028% mcap9.5% of flowOrdinary SharesSEC:0001213900-26-098775:0
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    CEOExecutivesYD Bio Ltd
    67,447 USD30SEC
    18,378 shares@ US$3.670.017% mcap52.4% of flowOrdinary SharesSEC:0001213900-26-098030:0
    Canonical exit: 3 Dec 2026 (T+90)

3 of 3 declarations